Literature DB >> 19845975

The feasibility of harmonizing health technology assessments across jurisdictions: a case study of drug eluting stents.

Paul Trueman1, Manjusha Hurry, Matthew Bending, John Hutton.   

Abstract

OBJECTIVES: There is considerable interest in the potential for harmonizing health technology assessments (HTA) across jurisdictions. This study aims to consider four HTAs of drug eluting stents to determine the degree to which the methods adopted, evidence considered, and resulting recommendations diverge.
METHODS: Four HTAs of drug eluting stents were selected for inclusion and evaluated using a framework developed to systematically capture information on the process adopted, the evidence considered and the recommendations of each HTA. RESULTS AND
CONCLUSIONS: The findings suggest that, although there is a common core data set considered by most of the agencies, differences in the approach to HTA, heterogeneity of studies, and the limited relevance of research findings to local practice meant that the core data set had only limited influence on the resulting recommendations. Of the HTA agencies considered in the analysis, many sought to generate additional primary research from local settings to help inform the development of recommendations that were relevant to local practice. This raises questions about the extent to which HTA methods can be harmonized across jurisdictions.

Mesh:

Year:  2009        PMID: 19845975     DOI: 10.1017/S0266462309990389

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  3 in total

1.  Critical Review of European Health-Economic Guidelines for the Health Technology Assessment of Medical Devices.

Authors:  Maximilian Blüher; Sita J Saunders; Virginie Mittard; Rafael Torrejon Torres; Jason A Davis; Rhodri Saunders
Journal:  Front Med (Lausanne)       Date:  2019-11-29

2.  Do different clinical evidence bases lead to discordant health-technology assessment decisions? An in-depth case series across three jurisdictions.

Authors:  Daryl S Spinner; Julie Birt; Jeffrey W Walter; Lee Bowman; Josephine Mauskopf; Michael F Drummond; Catherine Copley-Merriman
Journal:  Clinicoecon Outcomes Res       Date:  2013-01-30

Review 3.  Probiotics, prebiotics, and the host microbiome: the science of translation.

Authors:  Bryon Petschow; Joël Doré; Patricia Hibberd; Timothy Dinan; Gregor Reid; Martin Blaser; Patrice D Cani; Fred H Degnan; Jane Foster; Glenn Gibson; John Hutton; Todd R Klaenhammer; Ruth Ley; Max Nieuwdorp; Bruno Pot; David Relman; Andrew Serazin; Mary Ellen Sanders
Journal:  Ann N Y Acad Sci       Date:  2013-11-22       Impact factor: 5.691

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.